Stay updated on HMPL-813 in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the HMPL-813 in Glioblastoma Clinical Trial page.

Latest updates to the HMPL-813 in Glioblastoma Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the HMPL-813 (epitinib) glioblastoma study is displayed, including its design, eligibility criteria, outcome measure, and recruiting locations. The prior access-denied message is no longer shown.SummaryDifference44%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH notice about the terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2. The study record itself remains unavailable behind a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now renders a 403 Forbidden error. The previous study content and navigation are replaced by an access-denied screen.SummaryDifference17%

- Check61 days agoChange DetectedThe page shows a new revision number, updating from v3.6.6 to v3.7.0, indicating a newer release of the ClinicalTrials.gov page. This upgrade appears to be a general page update rather than a change to the study content or fields.SummaryDifference0.1%

Stay in the know with updates to HMPL-813 in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-813 in Glioblastoma Clinical Trial page.